Published 2008 | Version v1
Publication

Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results

Additional details

Created:
April 14, 2023
Modified:
December 1, 2023